| Literature DB >> 32454827 |
Aqsa Kamal1,2, Basheer Salman1, Noor Hayati Abdul Razak2, Ali Al Qabbani1, A R Samsudin1.
Abstract
BACKGROUND: A dry socket also referred to as alveolar osteitis (AO) is a common postoperative complication following tooth extraction, due to the disruption of the clot within the wound. This study aimed to evaluate the efficacy of concentrated growth factor (CGF) in the healing of alveolar osteitis following tooth extraction.Entities:
Year: 2020 PMID: 32454827 PMCID: PMC7240629 DOI: 10.1155/2020/9038629
Source DB: PubMed Journal: Int J Dent ISSN: 1687-8728
Figure 1Molecular mechanism of alveolar osteitis. Plasminogen type-1 is the precursor of plasmin which acts in fibrin degradation. Plasmin inhibitor sterically shields the active site of plasmin, thus substantially decreasing plasmin's access to protein substrates [15]. t-PA: tissue-type plasminogen activator; FDP: fibrin degradation products.
Figure 2Visual analogue pain scale (VAS) for recording the pain level of patients for dry socket [30, 31].
Patient demography.
| Mean (standard deviation, SD) | Frequency (percentage %) | |
|---|---|---|
| Age | 38.03 (8.96) | |
| Gender | ||
| Male | 25 (62.5) | |
| Female | 15 (37.5) |
Pain and granulation tissue (GT) score of subjects in group I and group II at days 0, 4, and 7.
| Patient no. | Age | Gender | Treatment option | Day 0 | Day 4 | Day 7 | |||
|---|---|---|---|---|---|---|---|---|---|
| Pain before treatment | GT | Pain | GT | Pain | GT | ||||
| 1 | 53 | Female | CGF | 7 | Nil | 0 | + | 0 | ++ |
| 2 | 39 | Female | CGF | 8 | Nil | 0 | ++ | 0 | +++ |
| 3 | 28 | Male | Control | 10 | Nil | 6 | Nil | 3 | + |
| 4 | 35 | Male | Control | 9 | Nil | 5 | + | 5 | + |
| 5 | 38 | Male | Control | 8 | Nil | 6 | Nil | 3 | + |
| 6 | 33 | Male | CGF | 9 | Nil | 1 | ++ | 0 | +++ |
| 7 | 38 | Male | CGF | 8 | Nil | 0 | ++ | 0 | ++ |
| 8 | 29 | Male | CGF | 9 | Nil | 0 | + | 0 | +++ |
| 9 | 40 | Female | Control | 10 | Nil | 5 | Nil | 3 | + |
| 10 | 49 | Female | Control | 8 | Nil | 4 | Nil | 3 | + |
| 11 | 42 | Male | Control | 9 | Nil | 5 | Nil | 0 | + |
| 12 | 40 | Female | CGF | 9 | Nil | 1 | ++ | 0 | +++ |
| 13 | 38 | Female | CGF | 7 | Nil | 0 | + | 0 | +++ |
| 14 | 40 | Male | CGF | 7 | Nil | 0 | ++ | 0 | ++ |
| 15 | 35 | Male | Control | 8 | Nil | 4 | Nil | 0 | + |
| 16 | 32 | Female | Control | 8 | Nil | 5 | Nil | 4 | + |
| 17 | 49 | Male | CGF | 8 | Nil | 1 | ++ | 0 | ++ |
| 18 | 31 | Male | CGF | 8 | Nil | 0 | ++ | 0 | +++ |
| 19 | 42 | Female | Control | 7 | Nil | 3 | Nil | 5 | + |
| 20 | 36 | Male | Control | 8 | Nil | 5 | Nil | 3 | + |
| 21 | 27 | Male | Control | 10 | Nil | 6 | Nil | 4 | + |
| 22 | 42 | Female | Control | 8 | Nil | 5 | + | 3 | + |
| 23 | 36 | Male | Control | 9 | Nil | 6 | Nil | 4 | + |
| 24 | 51 | Male | Control | 8 | Nil | 4 | Nil | 3 | + |
| 25 | 35 | Female | Control | 10 | Nil | 6 | + | 3 | + |
| 26 | 49 | Male | Control | 9 | Nil | 7 | Nil | 2 | + |
| 27 | 60 | Male | Control | 9 | Nil | 6 | Nil | 3 | + |
| 28 | 40 | Female | Control | 8 | Nil | 5 | Nil | 3 | + |
| 29 | 47 | Male | Control | 8 | Nil | 7 | Nil | 2 | + |
| 30 | 40 | Female | Control | 7 | Nil | 7 | Nil | 4 | + |
| 31 | 57 | Male | Control | 10 | Nil | 6 | + | 4 | ++ |
| 32 | 36 | Female | Control | 8 | Nil | 6 | Nil | 4 | + |
| 33 | 23 | Male | Control | 9 | Nil | 6 | + | 4 | ++ |
| 34 | 23 | Male | Control | 8 | Nil | 5 | Nil | 4 | + |
| 35 | 27 | Male | Control | 8 | Nil | 4 | Nil | 3 | ++ |
| 36 | 23 | Male | Control | 8 | Nil | 4 | Nil | 2 | + |
| 37 | 40 | Female | Control | 10 | Nil | 4 | + | 2 | ++ |
| 38 | 38 | Male | Control | 10 | Nil | 5 | + | 3 | ++ |
| 39 | 30 | Male | Control | 9 | Nil | 4 | Nil | 3 | + |
| 40 | 30 | Female | Control | 9 | Nil | 4 | Nil | 2 | + |
Scoring system employed for granulation tissue (GT) formation in the dry socket.
| Clinical presentation of GT | GT presence | GT score |
|---|---|---|
|
| No GT | Nil |
|
| GT in one quarter or less | + |
|
| GT in two quarters | ++ |
|
| GT in three quarters | +++ |
|
| GT in four quarters | ++++ |
Pain score among groups I and II.
| Day | Group | Mean rank |
|
|---|---|---|---|
| Day 0 | Group I | 22.37 | 0.065 |
| Group II | 14.90 | ||
|
| |||
| Day 4 | Group I | 25.50 | 0.001 |
| Group II | 5.50 | ||
|
| |||
| Day 7 | Group I | 25.17 | 0.001 |
| Group II | 6.50 | ||
Granulation tissue score in groups I and II.
| Day | Group | Mean rank |
|
|---|---|---|---|
| Day 4 | Group I | 16.08 | 0.001 |
| Group II | 33.75 | ||
|
| |||
| Day 7 | Group I | 15.83 | 0.001 |
| Group II | 34.50 | ||